GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Beese Fulmer Investment Management Inc.

Beese Fulmer Investment Management Inc. trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,893 shares of the company’s stock after selling 253 shares during the quarter. Beese Fulmer Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $459,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in GEHC. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 9.2% during the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after purchasing an additional 4,107,746 shares in the last quarter. Capital Research Global Investors grew its stake in GE HealthCare Technologies by 5.2% during the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after buying an additional 2,647,204 shares during the last quarter. Marshall Wace LLP acquired a new position in GE HealthCare Technologies during the second quarter worth approximately $63,639,000. Jacobs Levy Equity Management Inc. lifted its stake in GE HealthCare Technologies by 4,959.8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock valued at $68,957,000 after buying an additional 743,523 shares during the last quarter. Finally, International Assets Investment Management LLC grew its position in shares of GE HealthCare Technologies by 10,227.3% during the third quarter. International Assets Investment Management LLC now owns 621,913 shares of the company’s stock worth $58,367,000 after acquiring an additional 615,891 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $88.90 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.55. The firm has a market capitalization of $40.58 billion, a P/E ratio of 25.99, a PEG ratio of 3.39 and a beta of 1.18. The company’s fifty day moving average is $88.35 and its two-hundred day moving average is $83.45.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. Analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts recently commented on GEHC shares. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target for the company. Evercore ISI increased their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a report on Wednesday, September 18th. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $94.23.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.